ASPI - ASP Isotopes Inc. Common Stock

Strong Sell Momentum: Bearish

Recent News

ASP Isotopes Inc. and IsoBio, Inc. Announce Series Seed Funding of IsoBio, Inc. to Advance Innovative Antibody-Isotope Conjugates ( AICsTM ) For Cancer Treatment

GlobeNewswire • 1 month, 2 weeks ago • score: 0.18

- IsoBio, Inc. ( IsoBio ) is a U.S.-based radiotherapeutic development company focused on developing a broad pipeline of mAb-based radioisotope therapeutics, known as antibody-isotope conjugates ( AICsTM ) , targeting both derisked and novel tumor antigens for patients in need of new cancer ...

Bullish

ASPI Stock Soars Amid Isotope Production Milestones, Capacity Boost: What Investors Need To Know - ASP Isotopes ( NASDAQ:ASPI )

Benzinga • 1 month, 4 weeks ago • score: 0.43

ASP Isotopes shares are surging Friday morning. Tim Melvin's system has spotted 10X winners like NVIDIA and Matador-see his next 6 picks and the options strategies to multiply gains at a free July 23 event. Register Here. ASP Isotopes Inc ASPI shares are surging Friday morning as the stock ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Range-Bound

As of 2025-09-10 (Snapshot)

Aspire Real Estate Investors, Inc. focuses on investing, developing, remodeling and managing a portfolio of multi-family properties in metropolitan areas of the United States. The company is headquartered in Irvine, California.

52W High

$11.68

52W Low

$2.12

MA Status:

50D: Below 200D: Above

Beta (~1 neutral, <0.9 lower risk)

3.38

Valuation

Rich

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

54.35

EV/EBITDA (<8 favorable)

-12.17

EV/Revenue (<3 favorable)

172.03

P/S (TTM) (<3 favorable)

164.61

P/B (<3 favorable)

29.89

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

22.39%

Institutions (25–75% balanced)

45.31%

Shares Outstanding

91,913,000

Float

66,935,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

4,581,500

Gross Profit (TTM)

1,798,700

EPS (TTM)

-1.40

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

-9.99%

ROE (TTM) (>15% strong)

-4.70%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

0.17

Momentum

Bearish momentum

Value

-0.3368

-0.3573

Trend

Rising

Signal Cross

No cross

As of

Sep. 11, 2025